UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example MedicinalProductDefinition: EMLA-2525-Plaster-SE-AJ-MPD

Generated Narrative: MedicinalProductDefinition EMLA-2525-Plaster-SE-AJ-MPD

identifier: http://ema.europa.eu/fhir/mpId/SE-100001718-00011834, http://ema.europa.eu/fhir/eurdId/1867

domain: Human use

status: Current

combinedPharmaceuticalDoseForm: Medicated plaster

indication:

Emla plåster används vid: • Ytanestesi av intakt hud i samband med: o nålstick, t.ex. vid inläggning av perifer venkateter eller vid blodprovstagning o ytliga kirurgiska ingrepp, hos vuxna och den pediatriska populationen

legalStatusOfSupply: Medicinal product subject to medical prescription exempt for some pack sizes

classification: combinations

name

productName: EMLA 25 mg/25 mg Medicinskt plåster

part

part: EMLA

type: Invented Name Part

part

part: 25 mg/25 mg

type: Strength part

part

part: Medicinskt plåster

type: Pharmaceutical dose form part

Usages

-CountryLanguage
*Kingdom of SwedenSwedish